Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Iopromide. A new non-ionic contrast medium.

P Dawson, A Bradshaw, C Hill

    Acta Radiologica: Diagnosis
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Maintenance durvalumab after first-line chemotherapy in patients with HER2-negative advanced oesophago-gastric adenocarcinoma: results from the randomised PLATFORM study.

    ESMO open·2024
    Same author

    Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer's Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project.

    The journal of prevention of Alzheimer's disease·2024
    Same author

    Biologically derived epicardial patch induces macrophage mediated pathophysiologic repair in chronically infarcted swine hearts.

    Communications biology·2023
    Same author

    Comparison of the effects of FLOT and ECX chemotherapy for oesophagogastric adenocarcinoma on cardiopulmonary reserve.

    The British journal of surgery·2021
    Same author

    Hypofractionated Concomitant Chemoradiation in Inoperable Locally Advanced Non-small Cell Lung Cancer: A Report on 100 Patients and a Systematic Review.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2018
    Same author

    Analysis of hematopoietic recovery after autologous transplantation as method of quality control for long-term progenitor cell cryopreservation.

    Bone marrow transplantation·2017
    Same journal

    Cardiovascular responses to the intracarotid injections of ionic contrast media and iohexol in the dog.

    Acta radiologica: diagnosis·1986
    Same journal

    Computed chest tomography in rats with pulmonary damage due to microembolism.

    Acta radiologica: diagnosis·1986
    Same journal

    Value of bone scan in the McCune-Albright syndrome. Report of a case.

    Acta radiologica: diagnosis·1986
    Same journal

    Inadvertently performed hysterosalpingography during early pregnancy.

    Acta radiologica: diagnosis·1986
    Same journal

    Barium and meat. A comparison between pharyngeal swallow of fluid and solid boluses.

    Acta radiologica: diagnosis·1986
    Same journal

    Pharyngeal swallowing in patients with paresis of the recurrent nerve.

    Acta radiologica: diagnosis·1986
    See all related articles

    The new non-ionic contrast agent, iopromide, shows low chemotoxicity comparable to iopamidol. It is a safe alternative to conventional contrast media due to its favorable osmolality and viscosity.

    Area of Science:

    • Radiology and Medical Imaging
    • Pharmacology

    Background:

    • Conventional contrast media can exhibit significant chemotoxicity.
    • Development of low osmolality contrast agents aims to reduce adverse effects.
    • Iopromide is a new non-ionic contrast agent.

    Purpose of the Study:

    • To evaluate the physicochemical properties of iopromide.
    • To assess the chemotoxicity of iopromide compared to conventional and other non-ionic agents.

    Main Methods:

    • Comparison of osmolality and viscosity.
    • Assessment of protein binding.
    • Evaluation of enzyme inhibition.
    • Analysis of effects on the coagulation cascade.

    Main Results:

    Related Experiment Videos

    • Iopromide exhibits osmolality and viscosity comparable to other low osmolality media.
    • Chemotoxicity of iopromide is significantly lower than conventional media.
    • Iopromide's chemotoxicity is similar to the established non-ionic agent, iopamidol.

    Conclusions:

    • Iopromide demonstrates favorable physicochemical properties.
    • Iopromide exhibits a significantly reduced chemotoxicity profile.
    • Iopromide represents a safe and effective non-ionic contrast agent.